32140-51-5

Basic information

• Product Name: ACETYL COENZYME A (C2:0) LITHIUM
• Synonyms: ACETYL COENZYME A (C2:0) LITHIUM;Acetyl coenzyme A trilithium salt,Acetyl-S-CoA Li3;Coenzyme A, S-acetate,lithium salt (8CI,9CI);Acetyl-CoA, Acetyl-S-CoA Li3
• CAS NO: 32140-51-5
• Molecular Formula: C23H35N7O17P3S.3Li
• Molecular Weight: 827.372
• Mol File: 32140-51-5.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: ?20°C
• Solubility: H2O: soluble100mg/mL, clear, colorless
• CAS DataBase Reference: ACETYL COENZYME A (C2:0) LITHIUM(CAS DataBase Reference)
• NIST Chemistry Reference: ACETYL COENZYME A (C2:0) LITHIUM(32140-51-5)
• EPA Substance Registry System: ACETYL COENZYME A (C2:0) LITHIUM(32140-51-5)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36/37
• WGK Germany: 3
• Hazardous Substances Data: 32140-51-5(Hazardous Substances Data)

Usage

Uses

Used in Biomedical Research:
ACETYL COENZYME A (C2:0) LITHIUM is used as a substrate in CAT reporter assays for the measurement of chloramphenicol acetyltransferase. This application is significant in studying the activity of the enzyme and its role in various cellular processes.
Used in Pharmaceutical Industry:
ACETYL COENZYME A (C2:0) LITHIUM is used as a key intermediate in the synthesis of various pharmaceutical compounds, including antibiotics and other therapeutic agents. Its involvement in essential metabolic pathways makes it a valuable target for drug development and design.
Used in Metabolic Studies:
ACETYL COENZYME A (C2:0) LITHIUM is used as a research tool in understanding the regulation and function of metabolic pathways, such as the citric acid cycle and fatty acid metabolism. This knowledge is crucial for developing therapies targeting metabolic disorders and diseases.
Used in Energy Production Research:
ACETYL COENZYME A (C2:0) LITHIUM is used as a model compound to study the mechanisms of energy production in cells. Understanding its role in cellular respiration and energy metabolism can provide insights into the development of novel strategies for improving energy efficiency and treating related conditions.

Biochem/physiol Actions

Alterations in the gene encoding acetyl-CoA have been linked to Alzheimer′s disease and mild cognitive impairment. Defects in the gene cause myasthenic syndrome associated with episodic apnea.